We are doing science for policy
The Joint Research Centre (JRC) is the European Commission's science and knowledge service which employs scientists to carry out research in order to provide independent scientific advice and support to EU policy.
The Nanobiotechnology Laboratory features state-of-the-art equipped facilities designed to foster interdisciplinary studies. A special emphasis lies on characterisation of nanomaterials, micro-nanoplastics, nanomedicines, advanced materials and their interactions with biological systems, as well as on the detection, identification and characterisation of nanomaterials in food and consumer products.
Nanomaterial characterisation including their interactions with biological systems (culture media, proteins, etc.).
Detection of nanomaterials and nano-microplastics in complex matrices.
Surface chemical analysis of macro and nanomaterials. Surface modification and nano-fabrication.
Biomolecular interaction studies, characterisation of antibodies and antigens, bio-interfaces characterisation.
Advanced material characterisation for non-bio-applications (energy, transport, circular economy, environment etc.).
Access to the research infrastructure is granted on the basis of Access Units (e.g. days or weeks of use, hours or sessions of beam time, processing time and gigabytes of data transmitted, etc.). Access Units are specific to the type and nature of each JRC research infrastructure that provides access.
For the Nanobiotechnology Laboratory the Unit of Access is 'Instrument days' which correspond to the use of one (1) instrument during one (1) day.
Estimated costs excluding consumables and expenses:
In view of the limited access to the JRC sites due to the COVID-19 pandemic, the research infrastructure will favour remote access. For as long as access restrictions to the JRC sites prevail, physical access of Users to the JRC sites will be limited as much as possible and will be granted only if necessary following the rules of the host country and of the European Commission.
* Payment of additional costs, excluding consumables and expenses, are waived for the present call.
The JRC may provide a financial or in-kind contribution to support Users to cover their costs of travel and subsistence (T&S) related to the User Stay Days, subject to the availability of funds, personnel and other resources to Users from User Institutions located in a country eligible for the Widening actions under the Horizon 2020 Specific Objective “Spreading Excellence and Widening Participation”.
Namely the countries are:
EU Member States: Bulgaria, Croatia, Cyprus, Czechia, Estonia, Hungary, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovakia and Slovenia, and
Associated Countries (subject to valid association agreements of third countries with Horizon 2020): Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, The Republic of North Macedonia, Georgia, Moldova, Montenegro, Serbia, Tunisia, Turkey and Ukraine.
A User Stay Day is a day of physical presence of a User at the concerned Research Infrastructure for Access related to the User Access Project. A User Stay Day counts as a registered entry to the JRC site where the Research Infrastructure is located.
Long-term stays are primarily for students and have a duration exceeding 20 User Stay Days.
The Lead User is invited to fill in the User travel and subsistence form and send it to JRC-OPEN-NANOBIOTECH@ec.europa.eu by the closing date of the call. For more information the Lead User may contact the JRC Research Infrastructure at JRC-OPEN-NANOBIOTECH@ec.europa.eu.
or, when users run the research infrastructure
Proposals will be evaluated in accordance to the following selection criteria:
The proposal must be prepared using the Relevance-driven Proposal Submission Form.
During preparation of the proposal, applicants are encouraged to:
The proposal should be submitted to JRC-RI-OPEN-ACCESS@ec.europa.eu by the closing date of the call.
In addition, the Lead User shall complete the Nanobiotechnology Laboratory List of equipment Form and send it to JRC-OPEN-NANOBIOTECH@ec.europa.eu by the closing date of the call.